MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding)
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Crohn Disease
|
0.020 |
AlteredExpression
|
disease |
LHGDN |
Increased expression of DC-SIGN+IL-12+IL-18+ and CD83+IL-12-IL-18- dendritic cell populations in the colonic mucosa of patients with Crohn's disease.
|
12594843 |
2003 |
Hepatitis C
|
0.060 |
AlteredExpression
|
disease |
LHGDN |
L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus.
|
15371595 |
2004 |
Virus Diseases
|
0.070 |
Biomarker
|
group |
BEFREE |
In the early events of human immunodeficiency virus type 1 (HIV-1) infection, immature dendritic cells (DCs) expressing the DC-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN) receptor capture small amounts of HIV-1 on mucosal surfaces and spread viral infection to CD4(+) T cells in lymph nodes (22, 34, 45).
|
15452205 |
2004 |
Human immunodeficiency virus (HIV) II infection category B1
|
0.040 |
Biomarker
|
disease |
BEFREE |
In the early events of human immunodeficiency virus type 1 (HIV-1) infection, immature dendritic cells (DCs) expressing the DC-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN) receptor capture small amounts of HIV-1 on mucosal surfaces and spread viral infection to CD4(+) T cells in lymph nodes (22, 34, 45).
|
15452205 |
2004 |
Infection
|
0.060 |
Biomarker
|
group |
LHGDN |
Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin mediates binding and internalization of Aspergillus fumigatus conidia by dendritic cells and macrophages.
|
15494514 |
2004 |
Aspergillosis
|
0.010 |
Biomarker
|
disease |
LHGDN |
Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin mediates binding and internalization of Aspergillus fumigatus conidia by dendritic cells and macrophages.
|
15494514 |
2004 |
HIV Infections
|
0.310 |
Biomarker
|
group |
CTD_human |
Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection.
|
15564514 |
2004 |
HIV Coinfection
|
0.300 |
Biomarker
|
disease |
CTD_human |
Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection.
|
15564514 |
2004 |
Human immunodeficiency virus (HIV) II infection category B1
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection.
|
15564514 |
2004 |
Dengue Fever
|
0.400 |
Biomarker
|
disease |
BEFREE |
These results indicate that CD209 has a crucial role in dengue pathogenesis, which discriminates between severe dengue fever and dengue hemorrhagic fever.
|
15838506 |
2005 |
Dengue Fever
|
0.400 |
Biomarker
|
disease |
CTD_human |
These results indicate that CD209 has a crucial role in dengue pathogenesis, which discriminates between severe dengue fever and dengue hemorrhagic fever.
|
15838506 |
2005 |
Severe Dengue
|
0.050 |
Biomarker
|
disease |
BEFREE |
These results indicate that CD209 has a crucial role in dengue pathogenesis, which discriminates between severe dengue fever and dengue hemorrhagic fever.
|
15838506 |
2005 |
Tuberculosis, Pulmonary
|
0.360 |
Biomarker
|
disease |
CTD_human |
Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis.
|
16379498 |
2006 |
Tuberculosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
After exclusion of significant population stratification in our cohort, we observed an association between two CD209 promoter variants (-871G and -336A) and decreased risk of developing tuberculosis.
|
16379498 |
2006 |
Infection
|
0.060 |
Biomarker
|
group |
LHGDN |
DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages.
|
16424204 |
2006 |
Human herpesvirus 8 infection
|
0.010 |
Biomarker
|
disease |
BEFREE |
In this study, we show that dendritic cell-specific ICAM-3 grabbing nonintegrin (DC-SIGN; CD209) is a receptor for HHV-8 infection of myeloid DCs and macrophages.
|
16424204 |
2006 |
Human immunodeficiency virus (HIV) II infection category B1
|
0.040 |
Biomarker
|
disease |
BEFREE |
It has been proposed that DC-SIGN targets HIV to a nondegradative compartment within DCs and DC-SIGN-expressing cells, allowing incoming virus to persist for several days before infecting target cells.
|
16501104 |
2006 |
Leukemia, T-Cell
|
0.010 |
Biomarker
|
disease |
LHGDN |
DC-SIGN facilitates fusion of dendritic cells with human T-cell leukemia virus type 1-infected cells.
|
16641270 |
2006 |
Leprosy
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here we sought to evaluate whether DC-SIGN interacts with the leprosy bacillus, Mycobacterium leprae, and whether DC-SIGN genetic variation influences the susceptibility and/or pathogenesis of the disease.
|
16698431 |
2006 |
Bile duct proliferation
|
0.010 |
Biomarker
|
disease |
BEFREE |
Novel differentially expressed genes in AH in comparison to ND and AS included claudins, osteopontin, CD209, selenoprotein and genes related to bile duct proliferation.
|
16797773 |
2006 |
Infection
|
0.060 |
Biomarker
|
group |
LHGDN |
DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytes.
|
16839201 |
2006 |
Celiac Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Initially, the case-control and familial studies did not find any association of the -336 A/G CD209 genetic variant with CD susceptibility.
|
16865785 |
2006 |
Celiac Disease
|
0.010 |
GeneticVariation
|
disease |
LHGDN |
Initially, the case-control and familial studies did not find any association of the -336 A/G CD209 genetic variant with CD susceptibility.
|
16865785 |
2006 |
Tuberculosis
|
0.100 |
GeneticVariation
|
disease |
LHGDN |
Analysis of DC-SIGN (CD209) functional variants in patients with tuberculosis.
|
17055357 |
2006 |